General

Showing 1601–1616 of 2282 results

Article: P2.04 Immune impairments of the multiple myeloma bone-marrow mesenchymal stromal cells
€3.03 Add to cart
Article: P2.04 Role of microvesicles derived from leukemic blast in DIC and thrombosis.
€3.03 Add to cart
Article: P2.05 Global HDAC enzymatic activity is a strong marker of poor prognosis in Chronic Lymphocytic Leukemia
€3.03 Add to cart
Article: P2.05 Intravenous immunoglobulins as a preventive treatment of maternofoetal platelet alloimmunisation
€3.03 Add to cart
Article: P2.05 Role of extracellular vesicles on multidrug resistance transfer between leukemia cells
€3.03 Add to cart
Article: P2.06 Cost Analysis of Immunotherapy Using Dendritic Cells for Acute Myeloid Leukemia Patients
€3.03 Add to cart
Article: P2.06 Diagnosis of lymphoma in a patient under treatment with azacytidine
€3.03 Add to cart
Article: P2.06 Salt but not glucocorticosteroïds enhances Th17 differentiation from naïve T cells in vitro
€3.03 Add to cart
Article: P2.07 Bing-Neel syndrome: report of two cases
€3.03 Add to cart
Article: P2.07 Characterization of a novel innate CD8+ T cell lineage generated in human thymus
€3.03 Add to cart
Article: P2.07 MPN with JAK2 V617F mutation and identical del20q11.2 in three first-degree relatives without identified germline defect
€3.03 Add to cart
Article: P2.08 EBV associated hemophagocytic lymphohistiocytosis: a common infection running a life-threatening course
€3.03 Add to cart
Article: P2.08 Effect of different peak integration methods on the accuracy of paraprotein quantification on serum protein electrophoresis: what is the clinical relevance?
€3.03 Add to cart
Article: P2.08 Short delay of occurrence of myelodysplasia after Peptide Receptor Radionuclide Therapy (PRRT) in neuroendocrine tumors (NETs)
€3.03 Add to cart
Article: P2.09 Impact of minimal residual disease monitoring on therapy in Belgian childhood acute lymphoblastic leukaemia
€3.03 Add to cart
Article: P2.09 Prekallikrein deficiency in a 15-year-old boy with Ménière’s disease: a case report
€3.03 Add to cart

Article: P2.04 Immune impairments of the multiple myeloma bone-marrow mesenchymal stromal cells

Article: P2.04 Role of microvesicles derived from leukemic blast in DIC and thrombosis.

Article: P2.05 Global HDAC enzymatic activity is a strong marker of poor prognosis in Chronic Lymphocytic Leukemia

Article: P2.05 Intravenous immunoglobulins as a preventive treatment of maternofoetal platelet alloimmunisation

Article: P2.05 Role of extracellular vesicles on multidrug resistance transfer between leukemia cells

Article: P2.06 Cost Analysis of Immunotherapy Using Dendritic Cells for Acute Myeloid Leukemia Patients

Article: P2.06 Diagnosis of lymphoma in a patient under treatment with azacytidine

Article: P2.06 Salt but not glucocorticosteroïds enhances Th17 differentiation from naïve T cells in vitro

Article: P2.07 Bing-Neel syndrome: report of two cases

Article: P2.07 Characterization of a novel innate CD8+ T cell lineage generated in human thymus

Article: P2.07 MPN with JAK2 V617F mutation and identical del20q11.2 in three first-degree relatives without identified germline defect

Article: P2.08 EBV associated hemophagocytic lymphohistiocytosis: a common infection running a life-threatening course

Article: P2.08 Effect of different peak integration methods on the accuracy of paraprotein quantification on serum protein electrophoresis: what is the clinical relevance?

Article: P2.08 Short delay of occurrence of myelodysplasia after Peptide Receptor Radionuclide Therapy (PRRT) in neuroendocrine tumors (NETs)

Article: P2.09 Impact of minimal residual disease monitoring on therapy in Belgian childhood acute lymphoblastic leukaemia

Article: P2.09 Prekallikrein deficiency in a 15-year-old boy with Ménière’s disease: a case report